Phosphodiesterase-5 inhibitors use and risk for mortality and metastases among male patients with colorectal cancer
Phosphodiesterase-5 (PDE5) inhibitors have been suggested to have an anti-tumor effect and block surgery-induced immunosuppression. Here, the authors show that postdiagnostic use of PDE5 inhibitors is associated with a decreased risk of colorectal cancerspecific mortality as well as a decreased risk...
Guardado en:
Autores principales: | Wuqing Huang, Jan Sundquist, Kristina Sundquist, Jianguang Ji |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c9027a3053744a7f8d8ec74a50045c97 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Association between post-diagnostic use of cholera vaccine and risk of death in prostate cancer patients
por: Jianguang Ji, et al.
Publicado: (2018) -
Family history of breast cancer as a second primary malignancy in relatives: a nationwide cohort study
por: Guoqiao Zheng, et al.
Publicado: (2021) -
High frequency of potential phosphodiesterase type 5 inhibitor drug interactions in males with HIV infection and erectile dysfunction.
por: Jason M Cota, et al.
Publicado: (2021) -
Familial Associations of Colorectal Cancer with Other Cancers
por: Hongyao Yu, et al.
Publicado: (2017) -
Contribution of sewage to occurrence of phosphodiesterase-5 inhibitors in natural water
por: Youngmin Hong, et al.
Publicado: (2021)